Iberogast

DRUG3 trials

Sponsors

University Hospital, Basel, Switzerland, Nantes University Hospital, Academisch Medisch Centrum

Conditions

Functional NauseaGastrointestinal Disorders in Parkinson's DiseaseHeartburn pyrosis

Phase 2

Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease

CompletedNCT02719496

Nantes University HospitalGastrointestinal Disorders in Parkinson's Disease

Start: 2016-04-01End: 2018-04-01Updated: 2026-09-14

Phase 3

The effect of Iberogast on heartburn in patients with functional dyspepsia

Active, not recruitingNL-OMON49070

Academisch Medisch CentrumHeartburn pyrosis

Start: 2017-06-15Target: 18Updated: 2024-02-28

Unknown Phase

Comparison of the Therapeutic Effect of Acupressure Therapy and Iberogast ® (STW-5) in Children With Functional Nausea

CompletedNCT02660970

University Hospital, Basel, SwitzerlandFunctional Nausea

Start: 2016-01-31End: 2020-09-16Updated: 2020-10-06